KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) EPS (Basic): 2010-2025

Historic EPS (Basic) for Pacira BioSciences (PCRX) over the last 16 years, with Sep 2025 value amounting to $0.12.

  • Pacira BioSciences' EPS (Basic) rose 103.86% to $0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.46, marking a year-over-year increase of 123.35%. This contributed to the annual value of -$2.15 for FY2024, which is 336.26% down from last year.
  • Latest data reveals that Pacira BioSciences reported EPS (Basic) of $0.12 as of Q3 2025, which was up 209.09% from -$0.11 recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' EPS (Basic) peaked at $0.56 during Q2 2023, and registered a low of -$3.11 during Q3 2024.
  • Its 3-year average for EPS (Basic) is -$0.10, with a median of $0.19 in 2024.
  • Per our database at Business Quant, Pacira BioSciences' EPS (Basic) soared by 1,250.00% in 2023 and then plummeted by 1,452.17% in 2024.
  • Quarterly analysis of 5 years shows Pacira BioSciences' EPS (Basic) stood at -$0.12 in 2021, then plummeted by 83.33% to -$0.22 in 2022, then spiked by 345.45% to $0.54 in 2023, then crashed by 35.19% to $0.35 in 2024, then soared by 103.86% to $0.12 in 2025.
  • Its last three reported values are $0.12 in Q3 2025, -$0.11 for Q2 2025, and $0.10 during Q1 2025.